Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Updated Recommendations on Chlorhexidine-Impregnated (C-I) Dressings

Updated Recommendations on the Use of Chlorhexidine-Impregnated Dressings for Prevention of Intravascular Catheter-Related Infections (2017)

Updated Recommendations on C-I Dressings – Print version [PDF – 267 KB]

Appendix to Updated Recommendations on C-I Dressings – Print version [PDF – 388 KB]

Notice

These recommendations supersede the chlorhexidine-impregnated dressing recommendations in Guidelines for the Prevention of Intravascular Catheter-Related Infections (2011)

Summary of Recommendations

These recommendations supersede only the two statements about C-I dressings in the section on Catheter Site Dressing Regimens (Recommendations 12 and 13) in the 2011 Guidelines.

# Recommendation Category
 1.a For patients aged 18 years and older:
Chlorhexidine-impregnated dressings with an FDA-cleared label that specifies a clinical indication for reducing catheter-related bloodstream infection (CRBSI) or catheter-associated blood stream infection (CABSI) are recommended to protect the insertion site of short-term, non-tunneled central venous catheters. (See Section 5.0 Implementation Considerations for Patients Aged 18 Years and Older).
IA
2.a For patients younger than 18 years:
Chlorhexidine-impregnated dressings are NOT recommended to protect the site of short-term, non-tunneled central venous catheters for premature neonates due to risk of serious adverse skin reactions.
IC
2.b For patients younger than 18 years:
Replace catheter site dressing if the dressing becomes damp, loosened, or visibly soiled. No recommendation can be made about the use of chlorhexidine-impregnated dressings to protect the site of short-term, non-tunneled central venous catheters for pediatric patients less than 18 years old and non-premature neonates due to the lack of sufficient evidence from published, high-quality studies about efficacy and safety in this age group.
Unresolved Issue

TOP